Clotting disorders and VTE Flashcards
Complications of DVT
Pulmonary embolism
Chronic venous insufficiency/ varicose veins
Thrombophlebitis
Post-thrombotic syndrome
Provoked DVT is definied as…
DVT with recent (within 3 months) clinical risk factor for VTE
Unprovoked DVT is definied as…
DVT with no major clinical risk factors
Clinical risk factors for DVT
Previous DVT
Trauma
Hypercoagulable state: thrombophilia, pregnancy, HRT/ COCP, malignancy, antiphospholipid syndrome
Venous stasis: recent surgery, long haul flight (>6 hours), wheelchair bound/ immobilised
Presentation of DVT
Unilateral, acute limb pain/ tenderness
- Most common leg
Pain triggered by weight bearing
Red, warm, swollen limb
Venous distention
Features of the 2-level DVT Wells score
Previous DVT
Coagulopathy
- Active cancer
Venous stasis
- Paralysis/ paresis/ plaster immobilisation
- Recently bedridden (3 days/ major surgery in last 12 weeks.
Clinical signs
- Whole leg swelling
- Pitting oedema
- Calf diameter >3cm from asymptomatic leg
- Collateral superifical veins
What is the indication for thrombolysis in DVT
Symptomatic iliofemoral DVT AND:
- Onset within 14 days
- Good functional status
- 1 year + life expectancy
- Low risk of bleeding
Medical management of unprovoked DVT
Investigation in DVT presentation scoring ‘likely’ on 2-level Wells score
Proximal leg vein ultrasound scan (Doppler)
- Within 4 hours
If scan not avilable
- D-dimer
- interim anticoagulation
Medications used for proximal DVT/ PE
First line
- Rivoraxaban
- Apixaban
2nd line
- LMWH for 5 days
- Followed by dabigatran/ edoxaban
- OR LMWH + warfarn for 5 days.
Patients receiving anti-coagulant treatment should be provided with what?
Anticoagulation alert card and booklet.
IVC filters are indicated when in DVT
Recurrent PEs
Contraindicated anticoagulation
Post-thrombotic syndrome describes…
Chronic venous hypertension after VTE.
Leads to
- Leg pain/ swelling
- Skin changes: hyperpigmentation, dermatitis, liposclerodermatitis, ulcers, gangrene
How long should anticoagulation for VTE be continued in active cancer
3 months
- Review then weigh risks/ benefits.
Complications of PE
Respiratory failure
Chronic thromboembolic pulmonary hypertension
Death